25458-44-0

Basic information

• Product Name: 4-(MethoxyMethoxy)benzoicacid
• Synonyms: 4-(MethoxyMethoxy)benzoicacid
• CAS NO: 25458-44-0
• Molecular Formula: C₉H₁₀O₄
• Molecular Weight: 182.1733
• EINECS: -0
• Mol File: 25458-44-0.mol
• Article Data: 20

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 4-(MethoxyMethoxy)benzoicacid(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(MethoxyMethoxy)benzoicacid(25458-44-0)
• EPA Substance Registry System: 4-(MethoxyMethoxy)benzoicacid(25458-44-0)

Safety Data

• Statements: 36
• Safety Statements: 26
• Hazardous Substances Data: 25458-44-0(Hazardous Substances Data)

Usage

General Description

4-(MethoxyMethoxy)benzoic acid, also known as methyl 4-(methoxymethoxy)benzoate, is a chemical compound that consists of a benzoic acid core with two methoxy groups attached to a single carbon atom. It is commonly used as an intermediate in the synthesis of pharmaceuticals, agrochemicals, and dyes. 4-(MethoxyMethoxy)benzoicacid has a wide range of applications in the chemical industry, including as a building block for the production of various organic compounds. It is often used as a reagent in organic synthesis and as a starting material for the preparation of esters and other functionalized derivatives. Additionally, 4-(MethoxyMethoxy)benzoic acid may also have potential applications in the field of medicinal chemistry due to its structural features and properties.

Upstream product

• 13057-17-5 bromethyl methyl ether 
• 99-76-3 methyl 4-hydroxylbenzoate 
• 6515-21-5 4-methoxymethoxy-benzaldehyde 
• 123-08-0 4-hydroxy-benzaldehyde 
• 120-47-8 Ethyl 4-hydroxybenzoate 
• 107-30-2 chloromethyl methyl ether 
• 99-96-7 4-hydroxy-benzoic acid 
• 139884-19-8 4-(methoxymethoxy)benzoic acid methyl ester 
• 94-26-8 4-hydroxybenzoic acid, butyl ester 
• 251640-53-6 n-butyl 4-(methoxymethoxy)benzoate 
• 5942-30-3 ethyl 4-(methoxymethoxy)benzoate 

Downstream Products

• 149587-04-2 C₂₃H₂₀O₇ 
• 848330-42-7 4-Methoxymethoxy-benzoic acid (3R,3aS,4R,6aR)-6a-isopropyl-2-methoxy-4-methyl-4-[2-(2-methyl-[1,3]dioxolan-2-yl)-ethyl]-hexahydro-cyclopenta[b]furan-3-yl ester 
• 761001-58-5 N-methoxy-4-(methoxymethoxy)-N-methylbenzamide 
• 1021343-09-8 4-methoxymethoxy-N-(1-methyl-1-phenylethyl)benzamide 
• 1345681-72-2 (S)-N-(2-(1-(chloromethyl)-5-hydroxy-9-methyl-2,3-dihydro-1H-benzo[e]indole-3-carbonyl)-imidazo[1,2-a]pyridin-6-yl)-4-(methoxymethoxy)benzamide 
• 178609-50-2 ethyl 3-(4-(methoxymethoxy)phenyl)-3-oxopropanoate 

Relevant articles and documents

First total synthesis of mariamide A

Mariamide A, a lignanamide isolated from the seeds of Silybum marianum, has demonstrated potential utility as an antioxidant and antidiabetic agent and possesses an 8-O-4′ neolignan skeleton. Herein, a first total synthesis of mariamide A is presented that proceeds in nine steps using vanillin as the starting material. The key steps for the preparation of mariamide A involve an I2-catalyzed bromomethoxylation of an alkene group, a nucleophilic substitution followed by a sequential elimination and a monoacylation reaction.

S1P1 AGONIST AND APPLICATION THEREOF

The present invention relates to a class of tricyclic compounds and an application thereof as a sphingosine 1-phosphate type 1 (S1P1) receptor agonist. The invention specifically relates to a compound represented by formula (II), and a tautomer and pharmaceutically acceptable salt of same.

COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY

Compounds and methods of modulating 15-PGDH activity, modulating tissue prostaglandin levels, treating disease, diseases disorders, or conditions in which it is desired to modulate 15-PGDH activity and/or prostaglandin levels include 15-PGDH inhibitors described herein.